A patent review of PRMT5 inhibitors to treat cancer (2018 - present)
{{output}}
Introduction: Protein arginine methyltransferase 5 (PRMT5) belongs to type II arginine methyltransferases. Since PRMT5 plays an essential role in mammalian cells, it can regulate various physiological functions, including cell gr... ...
